Swanrose plans to launch five products in health, hygiene segment

New Delhi: Betting on the health and hygiene segment, Swanrose India on Thursday launched a new hand sanitiser and plans to expand its portfolio in the coming months, according to a company official. It plans to introduce five products in the health and hygiene segment this year and is also looking to enter the South America and the Middle East markets.

The company is a wholly-owned subsidiary of US-based Swanrose Inc.

On Thursday, the company introduced the hand sanitiser under the brand name ‘Just Human‘ in India and the US markets simultaneously, claiming that it will protect the users 24 hours from getting infected with coronavirus.

Swanrose Inc CEO Roshini Sanah Jaiswal said, “it is the first hand sanitiser to provide extended protection. The 24-hour efficacy is backed by GLP Lab certification”

‘Just Human’ 24-hour hand sanitiser is made in India with proprietary US technology. The product has got USFDA registration and DCGI clearance in India, she added.

Presently, the company is getting its hand sanitiser manufactured here through a third party contract manufacturer from Punjab.

Initially, the company expects monthly sales of 1.5 crore from the Indian market.

“We are not one product company. Our vision is to grow,” she said, adding a couple of products are at the R&D stage, which will be intellectual property-protected products.

Swanrose started business in April 2020, by producing alcohol-based hand sanitisers. The first product launch was Aristocrat and Humaste, both alcohol-based hand sanitisers, in India and the USA.

Roshini Sanah Jaiswal is also the promoter and Chief Restructuring Officer of the Delhi-based liquor company Jagatjit Industries.

  • Related Posts

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India Limited has set up its new corporate office in Mumbai, marking an extension of company’s presence in India, reinforcing its ambition to transforming care by unlocking the…

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Exports of drugs and pharmaceuticals from the country have reported a growth of around 4.9% during the first six months of the current fiscal year, at $16.13 billion, as compared…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

    Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

    Cancer patient dies before ‘using’ Ayurvedic treatment, hospital to pay parents Rs 63,000

    Fake beauty products with ₹6.9L face value seized from two shops; owners arrested

    Fake beauty products with ₹6.9L face value seized from two shops; owners arrested